Ronglai Shen, Ph.D.
Affiliations: | 2007 | University of Michigan, Ann Arbor, Ann Arbor, MI |
Area:
Biostatistics BiologyGoogle:
"Ronglai Shen"Parents
Sign in to add mentor| Jeremy M. G. Taylor | grad student | 2007 | University of Michigan | |
| (Statistical methods in cancer genomics.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Cyrta J, Prandi D, Arora A, et al. (2022) Comparative genomics of primary prostate cancer and paired metastases: insights from 12 molecular case studies. The Journal of Pathology |
| Mo Q, Shen R, Guo C, et al. (2017) A fully Bayesian latent variable model for integrative clustering analysis of multi-type omics data. Biostatistics (Oxford, England) |
| Brat DJ, Verhaak RG, et al. (2015) Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. The New England Journal of Medicine. 372: 2481-98 |
| Shen R, Wang S, Mo Q. (2013) SPARSE INTEGRATIVE CLUSTERING OF MULTIPLE OMICS DATA SETS. The Annals of Applied Statistics. 7: 269-294 |
| Kandoth C, Schultz N, et al. (2013) Integrated genomic characterization of endometrial carcinoma. Nature. 497: 67-73 |
| Ho AL, Grewal RK, Leboeuf R, et al. (2013) Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer. The New England Journal of Medicine. 368: 623-32 |
| Bott M, Brevet M, Taylor BS, et al. (2011) The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma. Nature Genetics. 43: 668-72 |
| Fury MG, Haque S, Stambuk H, et al. (2011) A phase 2 study of pemetrexed plus gemcitabine every 2 weeks for patients with recurrent or metastatic head and neck squamous cell cancer. Cancer. 117: 795-801 |
| Varambally S, Laxman B, Mehra R, et al. (2008) Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancer. Neoplasia (New York, N.Y.). 10: 1285-94 |
| Yu J, Cao Q, Mehra R, et al. (2007) Integrative genomics analysis reveals silencing of beta-adrenergic signaling by polycomb in prostate cancer. Cancer Cell. 12: 419-31 |